RoB 2: a revised tool for assessing risk of bias in randomised trials
Jonathan A C Sterne,Jelena Savović,Matthew J Page,Roy G Elbers,Natalie S Blencowe,Isabelle Boutron,Christopher J Cates,Hung-Yuan Cheng,Mark S Corbett,Sandra M Eldridge,Jonathan R Emberson,Miguel A Hernán,Sally Hopewell,Asbjørn Hróbjartsson,Daniela R Junqueira,Peter Jüni,Jamie J Kirkham,Toby Lasserson,Tianjing Li,Alexandra McAleenan,Barnaby C Reeves,Sasha Shepperd,Ian Shrier,Lesley A Stewart,Kate Tilling,Ian R White,Penny F Whiting,Julian P T Higgins
DOI: https://doi.org/10.1136/bmj.l4898
2019-08-28
BMJ
Abstract:Assessment of risk of bias is regarded as an essential component of a systematic review on the effects of an intervention. The most commonly used tool for randomised trials is the Cochrane risk-of-bias tool. We updated the tool to respond to developments in understanding how bias arises in randomised trials, and to address user feedback on and limitations of the original tool.